Literature DB >> 16750623

RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.

A Faried1, L S Faried, H Kimura, M Nakajima, M Sohda, T Miyazaki, H Kato, N Usman, H Kuwano.   

Abstract

There is growing evidence that Rho proteins are deregulated by overexpression in tumours; and according to some reports, this correlates with disease progression. Our previous clinical study had demonstrated a correlation between RhoA expression and tumour progression in oesophageal squamous cell carcinoma (ESCC). These findings prompted us to study, using nude mice, pathological roles of Rho proteins in human ESCC cells. Western blot analysis in ESCC cell lines, in addition to cell proliferation and in vitro migration assays, were performed to observe the malignant potential of RhoA and RhoC in untransfected and transfected cells. Constitutively active RhoA, RhoC and dominant negative RhoA (dnRhoA) proteins were transfected to ESCC (TE-1 and TE-2) cells. The stably transfected cells were injected into nude mice, and the growth and metastasis of these cells to the lungs were analysed. Tumour tissues were then examined using immunohistochemical methods for proteins Ki-67 (MIB-1), FAK, MMP-1, MMP-9 and TIMP-3. Protein levels of RhoA and RhoC in ESCC cell lines were visualised by Western blotting, and showed highest expression in TE-2 cells. Results from the migration assay illustrated that both RhoA and RhoC play a role in migration of ESCC cells. In TE-2 transfected cells, RhoC showed greater migration compared to RhoA. By using an experimental metastasis model in nude mice, RhoA was found to promote more tumour growth than RhoC, whereas RhoC induced lung metastasis in comparison to RhoA. Ki-67 labelling index was used to evaluate the proliferation potential of tumour tissue inoculated from nude mice. In TE-2 cells RhoA gave a proliferation capacity of 24.8+/-0.5, which was significantly higher than those of TE-2 RhoC 10+/-0.4 (P<0.01). Strong immunoreactivity for FAK, MMP-1 and MMP-9 proteins was present in all tumour cells. By contrast, loss of TIMP-3 expression was observed in all tumour cells. In conclusion, our results indicate that pro-oncogenic Rho proteins are involved in promoting tumour growth, cell migration and metastasis in human ESCC cells in nude mice. The results from this study suggest that active Rho proteins may induce a transforming effect that leads to a malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750623     DOI: 10.1016/j.ejca.2006.02.012

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  29 in total

1.  RND1 is up-regulated in esophageal squamous cell carcinoma and promotes the growth and migration of cancer cells.

Authors:  Guo Xiang; Yang Yi; He Weiwei; Wu Weiming
Journal:  Tumour Biol       Date:  2015-08-07

2.  Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.

Authors:  Carlos Torre; Steven J Wang; Weiliang Xia; Lilly Y W Bourguignon
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-05

3.  RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.

Authors:  Megumi Iiizumi; Sucharita Bandyopadhyay; Sudha K Pai; Misako Watabe; Shigeru Hirota; Sadahiro Hosobe; Taisei Tsukada; Kunio Miura; Ken Saito; Eiji Furuta; Wen Liu; Fei Xing; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

4.  The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells.

Authors:  Shuli Xie; Mingguang Zhu; Guoyue Lv; Qiang Zhang; Guangyi Wang
Journal:  Med Oncol       Date:  2011-06-15       Impact factor: 3.064

5.  Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.

Authors:  Mozaffarul Islam; Jharna Datta; James C Lang; Theodoros N Teknos
Journal:  Oral Oncol       Date:  2014-02-22       Impact factor: 5.337

6.  Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.

Authors:  Koji Ueno; Hiroshi Hirata; Shahana Majid; Soichiro Yamamura; Varahram Shahryari; Z Laura Tabatabai; Yuji Hinoda; Rajvir Dahiya
Journal:  Mol Cancer Ther       Date:  2011-11-04       Impact factor: 6.261

7.  The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.

Authors:  Olga Korkina; Zhiwan Dong; Allison Marullo; Gregg Warshaw; Marc Symons; Rosamaria Ruggieri
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

8.  RhoC expression and head and neck cancer metastasis.

Authors:  Mozaffarul Islam; Giant Lin; John C Brenner; Quintin Pan; Sofia D Merajver; Yanjun Hou; Pawan Kumar; Theodoros N Teknos
Journal:  Mol Cancer Res       Date:  2009-10-27       Impact factor: 5.852

9.  A new mechanism of RhoA ubiquitination and degradation: roles of SCF(FBXL19) E3 ligase and Erk2.

Authors:  Jianxin Wei; Rachel K Mialki; Su Dong; Andrew Khoo; Rama K Mallampalli; Yutong Zhao; Jing Zhao
Journal:  Biochim Biophys Acta       Date:  2013-07-18

10.  The effect of RhoC siRNA on the invasiveness and proliferation of human cervical cancer cell line SiHa cells.

Authors:  Xiaoqi He; Ying Qian; Huilan Cai; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.